ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Donors"

  • 2018 American Transplant Congress

    Elevated Donor Terminal Creatinine Does Not Appear to Be Associated with Worse Outcomes in Kidney Transplantation

    S. Rayhill, J. Haldorson.

    U Washington, Seattly.

    There is justified reluctance to use kidneys from donors with significantly elevated creatinine as they may have severe, irreversible injury. Recently, thanks, in part to…
  • 2018 American Transplant Congress

    Pharmacological Defatting of Steatotic Human Livers Using a Novel Perfusion Solution during Normothermic Machine Perfusion

    Y. Boteon,1,2 J. Attard,1,2 R. Laing,1,2 A. Boteon,1 R. Bhogal,1 G. Reynold,2 D. Neil,1 H. Mergental,1 D. Mirza,1 S. Afford.2

    1National Institute for Health Research, Birmingham Liver Biomedical Research Centre, University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom; 2Liver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.

    Introduction: Steatosis is the leading reason for donor livers discarding and contributes significantly to the worsening shortage of organs for transplantation. Steatotic livers commonly fail…
  • 2018 American Transplant Congress

    Intentional Transplantation of Hepatitis C Positive Livers into Hepatitis Negative Recipients- Report of the First Case-Series in the World

    P. Martins, B. Movahedi, A. Ahearn, A. Bozorgzadeh.

    Dept. of Surgery, Univ of Massachusetts, Worcester, MA.

    Background: The current disparity between supply and demand of liver grafts has dramatically increased the waiting time and mortality on the waiting list. The recent…
  • 2018 American Transplant Congress

    Desensitization to Facilitate Matching in a Large, National Kidney Paired Exchange Clearinghouse

    C. Holscher,1 A. Thomas,1 K. Jackson,1 C. Haugen,1 M. Ronin,2 A. Waterman,3,4 A. Massie,1,5 J. Garonzik Wang,1 D. Segev.1,5

    1Johns Hopkins School of Medicine, Baltimore; 2National Kidney Registry, New York; 3David Geffen School of Medicine at UCLA, Los Angeles; 4Terasaki Research Institute, Los Angeles; 5Johns Hopkins School of Public Health, Baltimore.

    In kidney paired exchange (KPE) programs, the use of incompatible transplantation has been necessary to prevent long waiting times for sensitized candidates and to facilitate…
  • 2018 American Transplant Congress

    Outcomes from Brain Death Donors with Cardiac Arrest Accepted for Pancreas Transplantation

    P. Ventura-Aguiar,1 J. Ferrer,2 D. Paredes,3 C. Rodriguez,3 C. Fontdevilla,2 E. Esmatjes,4 J. Garcia-Valdecasas,2 F. Oppenheimer,1 F. Diekmann,1 M. Ricart.1

    1Nephrology and Kidney Transplant Department, Hospital Clinic, Barcelona, Spain; 2Hepatobiliopancreatic and Liver Transplant Department, Hospital Clinic, Barcelona, Spain; 3Organ Transplantation Coordination Department, Hospital Clinic, Barcelona, Spain; 4Diabetes Unit, Department of Endocrinology and Nutrition, Hospital Clinic, Barcelona, Spain.

    Donor selection has a major impact on pancreas transplantation. Cardiac arrest and hypoxemia produce an insult to endothelial cell and may increase the risk of…
  • 2018 American Transplant Congress

    Early Outcomes and Risk Factors after Five Years of a Nationwide Strategy for Kidney Transplantation with Controlled Circulatory Death Donor (cDCD)

    J. Portoles,1,2 M. Perez Saez,2 D. Hernandez,2 J. Juega,2 F. Moreso,2 N. Maruri,2 P. Lopez,1,2 E. Melilli,2 D. Navarro,2 E. de Souza,2 J. Ruiz,2 M. Mazuecos,2 A. Gutierrez,2 I. Perez-Flores,2 D. Janeiro,1,2 J. Pascual.2

    1Nephrology, H Puerta de Hierro, Madrid, Spain; 2Nephrology, Spanish Multicentre Sentra-GEODAS Group, Madrid, Spain.

    Study: prospective multicentre, systematic inclusion of every kidney transplants-KTx from controlled donation after circulatory death (cDCD) at joined units. Local center surgical and immunosuppressive protocols.Background:…
  • 2018 American Transplant Congress

    10-Year Outcomes of Renal Transplantation from Circulatory Death Donors with Increased Terminal Creatinine

    Y. Tomita, K. Iwadoh, I. Nakajima, S. Fuchinoue.

    Surgery III, Tokyo Women's Medical University, Tokyo, Japan.

    Background: To alleviate chronic renal graft shortages in Japan, donation after circulatory death (DCD) is an increasingly used organ resource. Organs from DCD donors with…
  • 2018 American Transplant Congress

    Improvement in Intermediate Graft Survival among Deceased Donor Recipients in the Last Decade Due to Improvements in Outcomes of Higher KDPI Kidney Recipients

    D. Keith.

    Medicine, Sacred Heart Hospital, Pensacola, FL, Turkey.

    Previous research by our group showed that intermediate graft survival of adult deceased donor kidney transplants between six months and three years post-transplant improved in…
  • 2018 American Transplant Congress

    Pre-Existing Allograft Diabetic Nephropathy from Diabetic Donor is Reversible after Kidney Transplantation in Non-Diabetic Recipient

    K. Hotta,1 D. Iwami,1 H. Harada,2 Y. Fukasawa,2 H. Okada,1 H. Higuchi,1 T. Hirose,2 N. Fukuzawa,2 N. Shinohara.1

    1Hokkaido University Hospital, Sapporo, Japan; 2Sapporo City General Hospital, Sapporo, Japan.

    【Introduction】The shortage of kidney donor has limited the treatment of patients with end-stage kidney disease. To use diabetic donor with normal renal function is would…
  • 2017 American Transplant Congress

    MELD-Based Allocation Leads to Inferior Survival After Liver Transplantation.

    P. Ritschl, L. Wiering, M. Hippler-Benscheidt, F. Aigner, M. Biebl, M. Schmelzle, K. Kotsch, J. Pratschke, R. Öllinger.

    Department of Surgery, Campus Virchow and Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany

    Introduction and BackgroundThe MELD-based allocation system has been implemented in Germany in 2006 in order to decrease waiting list mortality in patients with end stage…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 46
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences